Society of Hematologic Oncology | Association Partnerships

Latest from Society of Hematologic Oncology

Exploring CAR T-Cell Therapies in the Indolent Lymphoma Setting

September 10, 2021

Early data have shown the promise of CD19-directed chimeric antigen receptor T cells for indolent lymphoma treatment, but longer follow-up is needed to determine if these responses represent cures in these historically difficult-to-treat malignancies.